Search Results

Responses of prothrombin time and activated partial thromboplastin time to edoxaban in Japanese patients with non-valvular atrial fibrillation: characteristics of representative reagents in Japan (CVI ARO 7).

• Authors : Suzuki S; Department of Cardiovascular Medicine, The Cardiovascular Institute, 3-2-19 Nishi-azabu, Minato-ku, Tokyo, 106-0031, Japan. .; Morishima Y

Subjects: Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*blood ; Partial Thromboplastin Time/Partial Thromboplastin Time/Partial Thromboplastin Time/*methods ; Prothrombin Time/Prothrombin Time/Prothrombin Time/*methods

• Source: Heart and vessels [Heart Vessels] 2019 Dec; Vol. 34 (12), pp. 2011-2020. Date of Electronic Publication: 2019 May 23.Publisher: Springer Verlag Country of Publication: Japan NLM ID: 8511258 Publication Model: Print-Electronic Cited Medium:

Record details

Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature.

• Authors : Fujiwara K; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.; Shimizu J

Subjects: Blood Coagulation* ; Partial Thromboplastin Time* ; Prothrombin Time*

• Source: Rheumatology international [Rheumatol Int] 2019 Oct; Vol. 39 (10), pp. 1811-1819. Date of Electronic Publication: 2019 Aug 07.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Prolonged activated partial thromboplastin time in thromboprophylaxis with unfractionated heparin in patients undergoing cesarean section.

• Authors : Matsubara S; Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Tochigi, Japan. ; Usui R

Subjects: Cesarean Section* ; Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects

• Source: The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2010 Feb; Vol. 36 (1), pp. 58-63.Publisher: Wiley on behalf of the Japan Society of Obstetrics and Gynecology] Country of Publication: Australia NLM ID: 9612761

Record details

New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests.

• Authors : Shimomura, Daiki; Kumano, Osamu; Ueda, Kaori

Subjects: ANTICOAGULANTS; CHEMICAL reagents; DESCRIPTIVE statisticsJAPAN

• Source: International Journal of Laboratory Hematology; Dec2024, Vol. 46 Issue 6, p1084-1091, 8p

Record details

Sysmex Corp Files Chinese Patent Application for Method for Measuring Activated Partial Thromboplastin Time and Reagent Kit for Activated Partial Thromboplastin Time Measurement.

• Source: Global IP News: Measurement & Testing Patent News. 2022.

Record details

Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study.

• Authors : Yasaka, Masahiro; Yokota, Hiroyuki; Suzuki, Michiyasu

Subjects: PREMENSTRUAL syndrome; DRUG side effects; PARTIAL thromboplastin timeJAPAN

• Source: Cardiology & Therapy; Dec2023, Vol. 12 Issue 4, p723-740, 18p

Record details

Japan Patent Office Receives Sysmex Corp's Patent Application for Reagent for Activated Partial Thromboplastin Time Measurement and Usage Thereof.

• Source: Global IP News: Measurement & Testing Patent News. 2016.

Record details

New Atrial Fibrillation Findings Has Been Reported by Investigators at Cardiovascular Institute (ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients).

• Source: Biotech Week. 2015, pages. 560

Record details

Patent Issued for Activated Partial Thromboplastin Time Measuring Reagent, Activated Partial Thromboplastin Time Measuring Method, and Determination Method for Determining Presence Or Absence of Blood.

• Source: Biotech Week. 2013, pages. 766

Record details

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study.

• Authors : Yasaka, Masahiro¹ (AUTHOR); Yokota, Hiroyuki² (AUTHOR); Suzuki, Michiyasu³ (AUTHOR)

Subjects: *PARTIAL thromboplastin time; *ANTICOAGULANTS; *DRUG side effectsJAPAN

• Source: Cardiology & Therapy. Jun2020, Vol. 9 Issue 1, p167-188. 22p.

Record details